Duyuru • Jul 08
BlueRiver Acquisition Corp., Annual General Meeting, Jul 21, 2025 BlueRiver Acquisition Corp., Annual General Meeting, Jul 21, 2025. Location: goodwin procter llp, 620 eighth avenue, new york United States Duyuru • Apr 02
BlueRiver Acquisition Corp. announced delayed annual 10-K filing On 04/01/2025, BlueRiver Acquisition Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC. Duyuru • Nov 15
BlueRiver Acquisition Corp. announced delayed 10-Q filing On 11/14/2024, BlueRiver Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. Duyuru • Aug 15
BlueRiver Acquisition Corp. announced delayed 10-Q filing On 08/14/2024, BlueRiver Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. Duyuru • Jul 19
The Staff of NYSE Regulation Determines to Suspend Trading in the Class A Ordinary Shares and Units of BlueRiver Acquisition On July 15, 2024, NYSE American LLC announced that the staff of NYSE Regulation has determined to suspend trading in the Class A ordinary shares and units of BlueRiver Acquisition Corp. from NYSE American. The NYSE American had previously announced on February 2, 2024 an NYSE Regulation determination to delist all of the Company’s listed securities, which included Company’s Class A ordinary shares, units and redeemable warrants (collectively, “Securities”), and the Company appealed such delisting determination. On July 12, 2024, the Company withdrew its appeal. On July 3, 2024, the NYSE American suspended trading in the Company’s redeemable warrants as they were trading at an abnormally low selling price. On July 15, 2024, the NYSE American suspended trading in the Company’s Class A ordinary shares and units and delisted the Company’s Securities by filing a Form 25 with the Securities and Exchange Commission. The Company may submit an application to have its Securities quoted on the OTCQX Marketplace (“OTCQX”). The Company cannot provide any assurance that the Securities will commence or continue to trade on this market, whether broker-dealers will continue to provide public quotes of the Securities on this market, whether the trading volume of the Securities will be sufficient to provide for an efficient trading market or whether quotes for the Securities will continue on this market in the future. Duyuru • Jul 08
BlueRiver Acquisition Receives a Written Notice from NYSE American On July 3, 2024, BlueRiver Acquisition Corp. received a written notice from NYSE American LLC indicating that the staff of NYSE Regulation has determined to suspend trading in the redeemable warrants of the Company (BLUA WS) from NYSE American. The NYSE American had previously announced on February 2, 2024 an NYSE Regulation determination to delist all of the Company’s listed securities and will now suspend trading in the redeemable warrants as they are trading at an abnormally low price. Trading in the Company’s Class A ordinary shares (BLUA) and units (BLUA.U) will continue to trade on the NYSE American during the pendency of the Company’s appeal rights. Duyuru • Feb 08
BlueRiver Acquisition Receives Commencement of Delisting Notice from the NYSE American LLC On February 2, 2024, BlueRiver Acquisition Corp. (‘BlueRiver’ or the ‘Company’) received a letter from the NYSE American LLC (‘NYSE American’ or the ‘Exchange’) stating that the staff of NYSE Regulation has determined to commence proceedings to delist the Company’s Class A ordinary shares, Units and Rights (collectively, the ‘Securities’) pursuant to Sections 119(b) and 119(f) of the NYSE American Company Guide because the Company failed to consummate a business combination within 36 months of the effectiveness of its initial public offering registration statement, or such shorter period that the Company specified in its registration statement. At this time, the Securities have not been suspended and will continue to trade. As indicated in the letter from NYSE American, the Company has a right to a review of the delisting determination by a Committee of the Board of Directors of the Exchange, provided a written request for such review is requested no later than February 9, 2024. The Company intends to make such request. Duyuru • Jan 18
BlueRiver Acquisition Corp., Annual General Meeting, Feb 01, 2024 BlueRiver Acquisition Corp., Annual General Meeting, Feb 01, 2024, at 09:00 US Eastern Standard Time. Board Change • Jan 07
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Alok Sama was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Aug 16
High number of new and inexperienced directors There are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Co-Chairman & Co-CEO John Gregg is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Duyuru • Jul 25
Spinal Stabilization Technologies, LLC (“SST”) entered into a definitive business combination agreement to acquire BlueRiver Acquisition Corp. (NYSEAM:BLUA) from BlueRiver Ventures, LLC and others for approximately $260 million in a reverse merger transaction. Spinal Stabilization Technologies, LLC (“SST”) entered into a definitive business combination agreement to acquire BlueRiver Acquisition Corp. (NYSEAM:BLUA) from BlueRiver Ventures, LLC and others for approximately $260 million in a reverse merger transaction on July 21, 2023. Upon the closing of the proposed transaction between SST and BlueRiver, the combined company will operate as Spinal Stabilization Technologies and be listed on an approved stock exchange. SST shareholders will roll 100% of their existing SST equity holdings and are expected to own equity-linked securities representing approximately 70% of combined company on a non-fully diluted basis immediately following the closing of the proposed business combination, assuming 100% redemptions by BlueRiver’s public stockholders and a proposed future $40.0 million PIPE raise. Board of direcotrs of resulting issuer will consist of: Joe de Compiegne, Randall Mays, Vic Bertrand, Mark Novotny, and Dr. Phillips.
The transaction is subject to expiration of the waiting period under the HSR Act; regulatory approvals; the Class A common stock of Surviving company contemplated to be listed pursuant to the Merger agreement shall have been listed on an approved stock exchange; the requisite approval of the BlueRiver shareholders shall have been obtained; the requisite approval of the members of SST shall have been obtained; the registration statement on Form S-4 shall have become effective; BlueRiver shall have at least $5,000,001 of net tangible assets; and the satisfaction of other closing conditions, including the completion of mutual due diligence and a committed PIPE or other mutually satisfactory financing resulting in net proceeds of at least $10 million. BlueRiver’s and SST’s respective boards of directors have approved the transaction. The transaction is expected to close in the fourth quarter of 2023, or early 2024. Cohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC, acts as BlueRiver’s exclusive financial advisor and lead capital markets advisor. Dan Espinoza of Goodwin Procter LLP is acting as BlueRiver’s legal counsel. Kreager Mitchell, PLLC is acting as SST’s legal counsel. Duyuru • May 17
BlueRiver Acquisition Corp. announced delayed 10-Q filing On 05/16/2023, BlueRiver Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. Board Change • Feb 14
High number of new and inexperienced directors There are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Co-Chairman & Co-CEO John Gregg is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Duyuru • Nov 15
BlueRiver Acquisition Corp. announced delayed 10-Q filing On 11/14/2022, BlueRiver Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. Duyuru • May 18
BlueRiver Acquisition Corp. announced delayed 10-Q filing On 05/17/2021, BlueRiver Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. 